Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Harnessing Self-Assembling Peptide Nanofibers to Prime Robust Tumor-Specific Cd8 T Cell Responses in Mice Publisher Pubmed



Mohseninia A1 ; Dehghani P2 ; Bargahi A1 ; Radmalekshahi M3 ; Rahimikian R1 ; Movahed A1 ; Reza Farzaneh M4 ; Mohammadi M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
  2. 2. The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University Of Medical Sciences, Bushehr, Iran
  3. 3. Department of Pharmaceutical Biomaterials and Medical Biomaterials Research center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. School of Medicine, Bushehr University of Medical Sciences, Iran

Source: International Immunopharmacology Published:2022


Abstract

Induction of tumor-specific CD8 + T cell responses is known as a major challenge for cancer vaccine development; here we presented a strategy to improve peptide nanofibers-mounted antitumor immune responses. To this end, peptide nanofibers bearing class I (Kb)‐restricted epitope (Epi-Nano) were formulated with polyethylene imine backbone (Epi-Nano-PEI), and characterized using morphological and physicochemical characterization techniques. Nanofibers were studied in terms of their uptake by antigen-presenting cells (APCs), antigen cross-presentation capacity, and cytotoxic activity. Furthermore, nanofibers were assessed by their potency to induce NLRP3 inflammasome-related cytokines and factors. Finally, the ability of nanofibers to induce tumor-specific CD8 T cells and tumor protection were investigated in tumor-bearing mice. The formulation of Epi-Nano with PEI led to the formation of short strand nanofibers with a positive surface charge, a low critical aggregation concentration (CAC), and an increased resistance to proteolytic degradation. Epi-Nano-PEI was significantly taken up more efficiently by antigen-presenting cells (APCs), and was more potent in cross-presentation when compared to Epi-Nano. Moreover, Epi-Nano-PEI, in comparison to Epi-Nano, efficiently up-regulated the expression of NLRP3, caspase-1, IL-1b, IL18 and IL-6. Cell viability analysis showed that formulation of PEI with Epi-Nano not only abolished its cytotoxic activity, but surprisingly induced macrophage proliferation. Furthermore, it demonstrated that Epi-Nano-PEI triggered robust antigen-specific CD8+ T cell responses, and induced maximum antitumor response (tumor growth inhibition and prolonged survival) in tumor-bearing mice that were significantly higher compared to Epi-Nano. Taken together, the formulation of Epi-Nano with PEI is suggested as a promising strategy to improve nanofibers-mounted antitumor immune response. © 2022 Elsevier B.V.